黄芩苷抗肿瘤作用机制的研究进展

doi:10.3969/j.issn.1674-8115.2021.02.019

上海交通大学学报(医学版) ›› 2021, Vol. 41 ›› Issue (2): 246-250.doi: 10.3969/j.issn.1674-8115.2021.02.019

黄芩苷抗肿瘤作用机制的研究进展

刘梦珂(), 纪濛濛, 程林, 黄金艳, 孙晓建, 赵维莅, 王黎()

上海交通大学医学院附属瑞金医院血液科，上海市血液学研究所，医学基因组学国家重点实验室，国家转化医学研究中心，上海 200025

收稿日期:2020-01-03 出版日期:2021-02-28 发布日期:2021-02-28
通讯作者: 王黎 E-mail:lmk0619@163.com;wl_wangdong@126.com
作者简介:刘梦珂（1996—），女，硕士生；电子信箱：lmk0619@163.com。
基金资助:
国家自然科学基金(81520108003);上海市科学技术委员会课题(16JC1405800);上海市杰出青年医学人才培养资助计划;上海市教育委员会高峰高原学科建设计划(20152206);上海市人才基金(2017079);上海交通大学医学院高水平地方高校创新团队(SSMU-ZLCX20180801)

Research progress in anti-tumor effect and mechanism of baicalin

Meng-ke LIU(), Meng-meng JI, Lin CHENG, Jin-yan HUANG, Xiao-jian SUN, Wei-li ZHAO, Li WANG()

Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Institute of Hematology; State Key Laboratory of Medical Genomics; National Research Center for Translational Medicine, Shanghai 200025, China

Received:2020-01-03 Online:2021-02-28 Published:2021-02-28
Contact: Li WANG E-mail:lmk0619@163.com;wl_wangdong@126.com
Supported by:
National Natural Science Foundation of China(81520108003);Project of Science and Technology Commission of Shanghai Municipality(16JC1405800);Shanghai Outstanding Youth Medical Talents Training Funding Program;Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20152206);Shanghai Talent Development Fund(2017079);Innovative Research Team of High-Level Local Universities in Shanghai(SSMU-ZLCX20180801)

摘要/Abstract

摘要：

黄芩苷是从中药黄芩中提取出来的一种黄酮类化合物。研究表明其作为黄芩的有效成分之一，在抗氧化、抗炎症和抗病毒等方面均具有疗效。随着研究的深入，黄芩苷在抗肿瘤方面的作用被逐渐地认识，其对肿瘤的影响和抗肿瘤的作用机制，如阻滞肿瘤细胞周期、诱导肿瘤细胞凋亡、防治肿瘤转移和调节肿瘤微环境等，使其成为中药抗肿瘤研究的新热点。该文对黄芩苷抗肿瘤作用的研究现状进行综述，以期增进对其抗肿瘤机制的认识，为肿瘤治疗提供新的思路。

关键词: 黄芩苷, 抗肿瘤, 肿瘤凋亡, 肿瘤转移, 肿瘤微环境

Abstract:

Baicalin is one of the flavonoids extracted from the root of Chinese herb Scutellariabaicalensis, which is proved to be an effective component in fields of anti-oxidant, anti-inflammation and anti-virus. Based on further studies, baicalin is gradually known to have anti-tumor function. It has an impact on tumor via multiple mechanisms such as induction of tumor cell cycle arrest, induction of apoptosis of tumor cell, inhibition of tumor metastasis and regulation of tumor microenvironment, ranking it a hotspot in Chinese medicine of anti-tumor therapy. This article comprehensively reviews the previous studies on the anti-tumor effect of baicalin, in order to promote understanding of its anti-tumor mechanisms and provide a new insight in anti-tumor therapy.

Key words: baicalin, anti-tumor, tumor apoptosis, tumor metastasis, tumor microenvironment

中图分类号:

R285.6

刘梦珂, 纪濛濛, 程林, 黄金艳, 孙晓建, 赵维莅, 王黎. 黄芩苷抗肿瘤作用机制的研究进展[J]. 上海交通大学学报(医学版), 2021, 41(2): 246-250.

Meng-ke LIU, Meng-meng JI, Lin CHENG, Jin-yan HUANG, Xiao-jian SUN, Wei-li ZHAO, Li WANG. Research progress in anti-tumor effect and mechanism of baicalin[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 246-250.

参考文献 36

1	Xiang YN, Guo ZM, Zhu PF, et al. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science[J]. Cancer Med, 2019, 8(5): 1958-1975.
2	Ji MM, Huang YH, Huang JY, et al. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified[J]. Haematologica, 2018, 103(4): 679-687.
3	Dou J, Wang Z, Ma L, et al. Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence[J]. Oncotarget, 2018, 9(28): 20089-20102.
4	Yu Y, Pei MY, Li L. Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo[J]. Int J Clin Exp Med, 2015, 8(6): 8958-8967.
5	Lim S, Cdks Kaldis P., cyclins and CKIs: roles beyond cell cycle regulation[J]. Development, 2013, 140(15): 3079-3093.
6	Ren X, Zhang ZY, Tian J, et al. The downregulation of C-MYC and its target gene hTERT is associated with the antiproliferative effects of baicalin on HL-60 cells[J]. Oncol Lett, 2017, 14(6): 6833-6840.
7	Wang Z, Ma LM, Su MQ, et al. Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling[J]. Cell Death Dis, 2018, 9(2): 217.
8	Liu XL, Ding J, Meng LH. Oncogene-induced senescence: a double edged sword in cancer[J]. Acta Pharmacol Sin, 2018, 39(10): 1553-1558.
9	Salama R, Sadaie M, Hoare M, et al. Cellular senescence and its effector programs[J]. Genes Dev, 2014, 28(2): 99-114.
10	Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies[J]. Aging (Albany NY), 2016, 8(4): 603-619.
11	Gao C, Zhou YL, Li HT, et al. Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro[J]. Mol Med Rep, 2017, 16(6): 8729-8734.
12	Wang HW, Li HL, Chen FQ, et al. Baicalin extracted from Huangqin (RadixScutellariae Baicalensis) induces apoptosis in gastric cancer cells by regulating B cell lymphoma(Bcl-2)/Bcl-2-associated X protein and activating caspase-3 and caspase-9[J]. J Tradit Chin Med, 2017, 37(2): 229-225.
13	Chen HJ, Gao Y, Wu JL, et al. Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies[J]. Cancer Lett, 2014, 354(1): 5-11.
14	Huang Y, Hu JD, Zheng J, et al. Down-regulation of the PI3K/AKT signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin[J]. J Exp Clin Cancer Res, 2012, 31(1): 48.
15	You JW, Cheng J, Yu B, et al. Baicalin, a Chinese herbal medicine, inhibits the proliferation and migration of human non-small cell lung carcinoma (NSCLC) cells, A549 and H1299, by activating the SIRT1/AMPK signaling pathway[J]. Med Sci Monit, 2018, 24: 2126-2133.
16	Zhu YH, Fang J, Wang HD, et al. Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca²⁺-dependent pathway[J]. Drug Des Devel Ther, 2018, 12: 3247-3261.
17	Tao YL, Zhan SB, Wang YB, et al. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs[J]. Sci Rep, 2018, 8(1): 14477.
18	Jia YM, Chen LR, Guo SJ, et al. Baicalin induced colon cancer cells apoptosis through miR-217/DKK1-mediated inhibition of Wnt signaling pathway[J]. Mol Biol Rep, 2019, 46(2): 1693-1700.
19	Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition[J]. Sci Signal, 2014, 7(344): re8.
20	Chung H, Choi HS, Seo EK, et al. Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells[J]. Biochem Biophys Res Commun, 2015, 458(3): 707-713.
21	Zhou T, Zhang AJ, Kuang G, et al. Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling[J]. Oncol Rep, 2017, 38(6): 3599-3607.
22	Wang YM, Wang HM, Zhou RH, et al. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor‑β1-induced epithelial-to-mesenchymal transition[J]. Anti-Cancer Drugs, 2017, 28(6): 581-587.
23	Lv Y, Zhao XM, Zhu LD, et al. Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis[J]. Theranostics, 2018, 8(10): 2830-2845.
24	Wang XF, Zhou QM, Du J, et al. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway[J]. Anticancer Agents Med Chem, 2013, 13(6): 923-931.
25	张悦, 符乔珊, 刘韡, 等. 黄芩苷对宫颈癌HeLa细胞侵袭转移的抑制作用及其机制[J]. 西安交通大学学报(医学版), 2016, 37(4): 599-603.
26	Ke MY, Zhang ZH, Xu BY, et al. Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells[J].Int Immunopharmacol, 2019, 75: 105824.
27	Song TL, Nairismägi ML, Laurensia Y, et al. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma[J]. Blood, 2018, 132(11): 1146-1158.
28	Gao Y, Liu H, Wang HZ, et al. Baicalin inhibits breast cancer development via inhibiting IĸB kinase activation in vitro and in vivo[J]. Int J Oncol, 2018, 53(6): 2727-2736.
29	Gong WY, Wu JF, Liu BJ, et al. Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro[J]. Int J Oncol, 2014, 44(5): 1561-1570.
30	Orzechowska B, Chaber R, Wiśniewska A, et al. Baicalin from the extract of Scutellaria baicalensis affects the innate immunity and apoptosis in leukocytes of children with acute lymphocytic leukemia[J]. Int Immunopharmacol, 2014, 23(2): 558-567.
31	Cherng CH, Lee KC, Chien CC, et al. Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats[J]. J Formos Med Assoc, 2014, 113(8): 513-520.
32	Zhu WJ, Chen XQ, Yu JF, et al. Baicalin modulates the Treg/Teff balance to alleviate uveitis by activating the aryl hydrocarbon receptor[J]. Biochem Pharmacol, 2018, 154: 18-27.
33	Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics[J]. Adv Drug Deliv Rev, 2017, 114: 206-221.
34	Tan HY, Wang N, Man K, et al. Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin[J]. Cell Death Dis, 2015, 6: e1942.
35	Zheng J, Asakawa T, Chen YY, et al. Synergistic effect of baicalin and adriamycin in resistant HL-60/ADM leukaemia cells[J]. Cell Physiol Biochem, 2017, 43(1): 419-430.
36	Xu WF, Liu F, Ma YC, et al. Baicalin regulates proliferation, apoptosis, migration, and invasion in mesothelioma[J]. Med Sci Monit, 2019, 25: 8172-8180.

[1]	顾琦晟, 张米粒, 曹灿, 李继坤. 基于TCGA数据库分析胃癌可变剪接与肿瘤免疫的关系[J]. 上海交通大学学报(医学版), 2021, 41(4): 448-458.
[2]	潘德燊1, 2，李登1，邵怡1. 白细胞介素 -11对肿瘤促进作用的研究进展[J]. 上海交通大学学报（医学版）, 2020, 40(4): 548-.
[3]	赵伟光，刘志宏. 肿瘤相关成纤维细胞调控肿瘤免疫炎症微环境的研究进展[J]. 上海交通大学学报(医学版), 2020, 40(09): 1288-1293.
[4]	刘洁，仇晓春. 乳腺肿瘤干细胞研究热点及趋势分析[J]. 上海交通大学学报(医学版), 2020, 40(07): 881-888.
[5]	梁雨，江明杰，田聆. 前列腺素 E 2重塑胰腺肿瘤微环境的作用机制研究进展[J]. 上海交通大学学报（医学版）, 2019, 39(8): 923-.
[6]	徐忠匀，吴书其，王少雁，王丹阳，傅宏亮. 131I治疗分化型甲状腺癌伴肺转移的效果评价及其影响因素分析[J]. 上海交通大学学报（医学版）, 2019, 39(4): 412-.
[7]	吴迪，齐隽. 介孔硅基活性氧可控释放纳米体系及其抗肿瘤应用进展[J]. 上海交通大学学报（医学版）, 2019, 39(11): 1329-.
[8]	徐俊杰 1，杨然 1，杨芳景 1，焦鑫 1，刘颖斌 2. 吴茱萸碱抗肿瘤机制的研究进展[J]. 上海交通大学学报（医学版）, 2018, 38(5): 578-.
[9]	刘进权1，谢冰2. BV8及其抗体与血管新生的关系[J]. 上海交通大学学报（医学版）, 2018, 38(4): 472-.
[10]	龚蔚，孟周文理*，田娜，林冠乔，付天然，张良. Tet：基于DNA去甲基化的全新抗肿瘤药物靶标[J]. 上海交通大学学报（医学版）, 2017, 37(04): 551-.
[11]	马静，沈鸣，段友容，杜联芳 . 载紫杉醇纳米诊疗体的制备及初步应用[J]. 上海交通大学学报（医学版）, 2017, 37(02): 166-.
[12]	卜时夏，赖东梅. 卵巢癌相关成纤维细胞的研究进展[J]. 上海交通大学学报（医学版）, 2016, 36(08): 1242-.
[13]	张生军，刘敏丽，常琦，刘勇峰. 姜黄素通过靶向PBK对结直肠癌HCT116细胞增殖的抑制作用[J]. 上海交通大学学报（医学版）, 2016, 36(07): 980-.
[14]	傅于捷，高建新，李林凤，赵晓菁. NK细胞与NKDCs的相关性及功能研究[J]. 上海交通大学学报（医学版）, 2016, 36(06): 814-.
[15]	马大骅，黄楷，姜梦迪，徐菲菲，管艺贝，程枫. 凋亡抑制蛋白Livin在肿瘤中的作用及其诊断和治疗应用进展[J]. 上海交通大学学报（医学版）, 2016, 36(05): 782-.

黄芩苷抗肿瘤作用机制的研究进展

Research progress in anti-tumor effect and mechanism of baicalin

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 15

编辑推荐

Metrics